Related Experiment Video
Updated: Jul 28, 2025

A Luciferase-fluorescent Reporter Influenza Virus for Live Imaging and Quantification of Viral Infection
Published on: August 14, 2019
Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016-2021
Jocelynne E McRae1,2, Lisa McHugh3, Catherine King1,2
1National Centre for Immunisation Research and Surveillance, Sydney, NSW.
Insights
Maternal vaccination against influenza and pertussis in Australia shows suboptimal coverage, particularly for influenza. Improving data collection is crucial for enhancing vaccination rates among at-risk pregnant women.
Area of Science:
- Public Health
- Immunisation
- Maternal Health
Background:
- Vaccination during pregnancy is vital for protecting infants from influenza and pertussis.
- Pregnant women face increased risks from influenza, preventable by antenatal vaccination.
- Australian National Immunisation Program funds maternal influenza and pertussis vaccines, but national coverage data is lacking.
Purpose of the Study:
- To review Australian maternal influenza and pertussis vaccine coverage data from 2016-2021.
- To identify gaps and information needs in current antenatal vaccination reporting.
Main Methods:
- Systematic review of reported Australian maternal influenza and pertussis vaccine coverage data (2016-2021).
- Analysis of jurisdictional perinatal data collections as a source of coverage information.
Main Results:
- Maternal influenza vaccine coverage was below 58% (2016-2018), improving to 62-75% in Victoria and Western Australia (2019-2021).
- Maternal pertussis vaccine coverage exceeded 70% (from 2016), with Western Australia reporting 89% in 2020.
- Suboptimal coverage observed in First Nations, culturally and linguistically diverse, and lower socio-economic status pregnant women.
Conclusions:
- Current antenatal vaccine coverage data in Australia is insufficient and lacks national consistency.
- Improved, timely data collection is essential for targeted interventions to boost maternal vaccination rates.
- Focus is needed on high-risk and low-uptake populations, and emerging vaccine recommendations like COVID-19.
Abstract:
Vaccination in pregnancy is the best strategy to reduce complications from influenza or pertussis infection in infants who are too young to be protected directly from vaccination. Pregnant women are also at risk of influenza complications preventable through antenatal vaccination. Both vaccines are funded under the National Immunisation Program for pregnant women in Australia, but coverage is not routinely reported nationally. We reviewed all reported Australian maternal influenza and pertussis vaccine coverage data for the period 2016-2021, to identify gaps and information needs. Maternal influenza vaccine coverage was suboptimal at < 58% for 2016-2018, with higher coverage of 62-75% reported in two states (Victoria and Western Australia) for 2019-2021. Maternal pertussis vaccine coverage from 2016 was generally higher than for influenza at > 70%, with the highest jurisdictional coverage of 89% reported in Western Australia in 2020. Vaccination rates were often suboptimal among First Nations pregnant women and up to 20% lower than among non-First Nations Australian women; while data were limited, coverage was low among culturally and linguistically diverse women and among women of lower socio-economic status. Jurisdictional perinatal data collections were the best source of information on antenatal vaccine coverage but were only available for a minority of the population; a nationally consistent systematic approach is lacking. Timely and comprehensive data are needed to provide feedback to improve maternal vaccination coverage, particularly among groups with higher risk and/or low uptake, and as new vaccines are recommended, including COVID-19 vaccination.
More Related Videos
08:52Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
Published on: July 26, 2019
10:47Using Bioluminescent Imaging to Investigate Synergism Between Streptococcus pneumoniae and Influenza A Virus in Infant Mice
Published on: April 14, 2011
Related Concept Videos
Vaccinations
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Teratogenicity
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...